Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm

Whole-genome landscape of pancreatic neuroendocrine tumours

(2017) Aldo Scarpa et al.   NATURE

Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift

(2017) Alessandra Fabbri et al.   VIRCHOWS ARCHIV

A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas

(2016) Laura H. Tang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study

(2016) Namrata Vijayvergia et al.   BRITISH JOURNAL OF CANCER

Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung

(2016) Tomohiro Miyoshi et al.   CLINICAL CANCER RESEARCH

Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets

(2016) N. Rekhtman et al.   CLINICAL CANCER RESEARCH

Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms

(2016) Stefano La Rosa et al.   ENDOCRINE PATHOLOGY

Pathologic Classification of Neuroendocrine Neoplasms

(2016) David S. Klimstra   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Thermodynamic measures of cancer: Gibbs free energy and entropy of protein–protein interactions

(2016) Edward A. Rietman et al.   JOURNAL OF BIOLOGICAL PHYSICS

Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role forTERT,RB1,MEN1andKMT2D

(2016) Michele Simbolo et al.   JOURNAL OF PATHOLOGY

Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer

(2016) Nicola Fusco et al.   MODERN PATHOLOGY

Glioblastoma: pathology, molecular mechanisms and markers

(2015) Kenneth Aldape et al.   ACTA NEUROPATHOLOGICA

Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group

(2015) Claudia Vollbrecht et al.   BRITISH JOURNAL OF CANCER

Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas

(2015) L. H. Tang et al.   CLINICAL CANCER RESEARCH

NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas

(2015) Lydia Meder et al.   INTERNATIONAL JOURNAL OF CANCER

The 2015 World Health Organization Classification of Lung Tumors

(2015) William D. Travis et al.   Journal of Thoracic Oncology

Definition of Primary and Secondary Glioblastoma--Response

(2014) H. Ohgaki et al.   CLINICAL CANCER RESEARCH

Tumor genetics and survival of thymic neuroendocrine neoplasms: A multi-institutional clinicopathologic study

(2014) Philipp Ströbel et al.   GENES CHROMOSOMES & CANCER

Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids

(2014) Lynnette Fernandez-Cuesta et al.   Nature Communications

An exploration of pathways involved in lung carcinoid progression using gene expression profiling

(2013) Dorian R.A. Swarts et al.   CARCINOGENESIS

CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids

(2013) D. R. A. Swarts et al.   CLINICAL CANCER RESEARCH

MEN1Gene Mutation and Reduced Expression Are Associated With Poor Prognosis in Pulmonary Carcinoids

(2013) Dorian R. A. Swarts et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Neuroendocrine tumours—challenges in the diagnosis and classification of pulmonary neuroendocrine tumours

(2013) M A den Bakker et al.   JOURNAL OF CLINICAL PATHOLOGY

Gastroenteropancreatic neuroendocrine neoplasms: Historical context and current issues

(2013) Zhaohai Yang et al.   SEMINARS IN DIAGNOSTIC PATHOLOGY

Molecular and cellular biology of neuroendocrine lung tumors: Evidence for separate biological entities

(2012) Dorian R.A. Swarts et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

(2012) Martin Peifer et al.   NATURE GENETICS

Deletions of 11q22.3-q25 Are Associated with Atypical Lung Carcinoids and Poor Clinical Outcome

(2011) Dorian R.A. Swarts et al.   AMERICAN JOURNAL OF PATHOLOGY

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

(2011) L. V. Sequist et al.   Science Translational Medicine

Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability

(2010) Michael A den Bakker et al.   HISTOPATHOLOGY

Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors

(2010) J. Voortman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases

(2009) L. Righi et al.   ANNALS OF ONCOLOGY

A small-cell lung cancer genome with complex signatures of tobacco exposure

(2009) Erin D. Pleasance et al.   NATURE